Your browser is no longer supported. Please, upgrade your browser.
QGEN [NYSE]
QIAGEN N.V.
Index- P/E64.56 EPS (ttm)0.82 Insider Own3.60% Shs Outstand228.73M Perf Week1.84%
Market Cap12.40B Forward P/E22.20 EPS next Y2.40 Insider Trans0.00% Shs Float216.70M Perf Month3.12%
Income191.40M PEG5.91 EPS next Q0.64 Inst Own63.20% Short Float2.19% Perf Quarter1.26%
Sales1.71B P/S7.24 EPS this Y-122.40% Inst Trans2.21% Short Ratio5.51 Perf Half Y10.53%
Book/sh11.85 P/B4.49 EPS next Y15.25% ROA3.60% Target Price56.42 Perf Year55.60%
Cash/sh2.15 P/C24.71 EPS next 5Y10.93% ROE7.40% 52W Range32.97 - 55.27 Perf YTD0.66%
Dividend- P/FCF69.21 EPS past 5Y-18.80% ROI0.40% 52W High-3.75% Beta0.31
Dividend %- Quick Ratio1.20 Sales past 5Y2.60% Gross Margin66.50% 52W Low61.38% ATR0.97
Employees5300 Current Ratio1.50 Sales Q/Q26.40% Oper. Margin18.10% RSI (14)60.22 Volatility1.28% 1.45%
OptionableYes Debt/Eq0.66 EPS Q/Q110.10% Profit Margin11.20% Rel Volume0.65 Prev Close53.19
ShortableYes LT Debt/Eq0.52 EarningsNov 04 AMC Payout0.00% Avg Volume861.25K Price53.20
Recom2.50 SMA201.17% SMA505.98% SMA20012.17% Volume558,237 Change0.02%
Oct-06-20Resumed BofA Securities Buy $59
Sep-28-20Upgrade Kepler Hold → Buy
Aug-24-20Upgrade Citigroup Neutral → Buy $48 → $62
Aug-20-20Resumed JP Morgan Overweight $60
Aug-17-20Upgrade Berenberg Hold → Buy
Aug-14-20Upgrade Exane BNP Paribas Neutral → Outperform
Aug-14-20Upgrade Deutsche Bank Hold → Buy
Mar-04-20Downgrade Berenberg Buy → Hold
Jan-08-20Initiated Wells Fargo Equal Weight $36
Jan-07-20Initiated Citigroup Neutral $35
Dec-26-19Resumed BofA/Merrill Underperform $28
Nov-15-19Initiated Stifel Hold
Nov-14-19Upgrade Kepler Reduce → Hold
Nov-14-19Upgrade JP Morgan Underweight → Overweight
Nov-14-19Upgrade Evercore ISI In-line → Outperform
Oct-17-19Upgrade Wolfe Research Peer Perform → Outperform
Oct-09-19Downgrade Kepler Hold → Reduce
Oct-08-19Downgrade JP Morgan Neutral → Underweight
Oct-08-19Downgrade Deutsche Bank Buy → Hold
Oct-08-19Downgrade Barclays Overweight → Equal Weight
Jan-14-21 01:52PM  
11:51AM  
Jan-13-21 09:52AM  
Jan-08-21 07:00AM  
07:00AM  
Jan-07-21 04:25PM  
Jan-01-21 11:16AM  
Dec-23-20 07:29PM  
Dec-21-20 09:33AM  
09:16AM  
Dec-17-20 04:05PM  
Dec-11-20 06:02PM  
Dec-08-20 10:18AM  
01:45AM  
Dec-07-20 02:00AM  
Nov-25-20 09:45AM  
Nov-23-20 02:28PM  
Nov-19-20 11:08AM  
Nov-18-20 04:05PM  
Nov-17-20 10:21AM  
10:09AM  
Nov-16-20 04:05PM  
10:20AM  
Nov-13-20 08:30AM  
Nov-12-20 01:11PM  
Nov-11-20 04:05PM  
Nov-09-20 03:52PM  
Oct-28-20 12:06PM  
Oct-27-20 03:05PM  
01:04PM  
12:59PM  
Oct-19-20 01:28PM  
Oct-16-20 09:00AM  
08:46AM  
Oct-15-20 09:00AM  
Oct-14-20 08:30AM  
Oct-13-20 08:45AM  
Oct-12-20 09:00AM  
08:48AM  
Oct-08-20 11:30AM  
08:38AM  
Oct-06-20 01:01PM  
12:53PM  
Oct-05-20 04:03PM  
Oct-02-20 12:00PM  
Sep-22-20 11:30AM  
Sep-18-20 09:02AM  
Sep-17-20 04:05PM  
Sep-16-20 09:55AM  
Sep-14-20 11:14PM  
09:41AM  
Sep-10-20 09:39AM  
Sep-09-20 10:23AM  
Sep-08-20 04:02PM  
08:59AM  
Sep-04-20 11:30AM  
Sep-03-20 11:31AM  
Aug-25-20 03:40PM  
09:19AM  
02:17AM  
Aug-24-20 04:02PM  
12:40PM  
Aug-21-20 11:52AM  
Aug-19-20 10:20AM  
Aug-18-20 04:05PM  
11:30AM  
10:29AM  
Aug-14-20 11:48AM  
Aug-13-20 09:39AM  
09:13AM  
08:30AM  
07:30AM  
Aug-11-20 09:23AM  
Aug-07-20 08:15PM  
Aug-05-20 08:55AM  
Aug-04-20 05:34PM  
04:06PM  
08:06AM  
Aug-03-20 12:22PM  
08:49AM  
Jul-28-20 12:33PM  
Jul-24-20 10:15AM  
Jul-22-20 09:04AM  
06:00AM  
Jul-16-20 08:45AM  
Jul-13-20 10:30AM  
07:04AM  
Jul-08-20 08:48AM  
Jul-07-20 10:24AM  
Jul-03-20 12:38PM  
09:39AM  
08:30AM  
Jul-02-20 08:46AM  
08:11AM  
Jul-01-20 09:45AM  
Jun-30-20 01:55PM  
10:40AM  
Jun-29-20 09:44AM  
Jun-24-20 09:50AM  
Jun-23-20 11:37AM  
QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. The company offers primary sample technology consumables, such as nucleic stabilization and purification kits designed for primary sample materials (deoxyribonucleic acid, ribonucleic acid, and proteins), manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and buffers; secondary sample technology consumables, including kits and components for purification of nucleic acids and proteins from secondary sample materials, and molecular biology reagents; and instruments for nucleic acid purification and accessories. It also provides assay content consumables, such as kits, assays, reagents, and controls for identification and analysis of sequence-specific targets, such as DNA, methylated DNA, bacterial DNA, RNA, and miRNA with various technologies, such as PCR, pyrosequencing, and hybridization in assay and array format, as well as oligonucleotide synthesis, siRNAs, and bisulfite conversion; custom-developed and configured enzymes and products; assay foundation consumables; modular PCR system, one-step molecular analysis of hard-to-diagnose syndromes, fully integrated medium to high throughput PCR test analysis, and specialized instruments; and custom laboratory and genomic services. In addition, the company offers predefined and custom next-generation sequencing gene panels (DNA and RNA), library prep kits and components, whole genome amplification, etc.; bioinformatics solutions; and human ID/forensics sample collection consumables and human ID/forensics sample collection consumables. It serves molecular diagnostics, applied testing, pharma, and academia customers. The company has collaboration agreements with Amgen Inc., CLIA-certified laboratories, and NuProbe Global. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.